AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CROMOGLYCATE DE SODIUM
21 registrations across 3 African markets— 15 active
Markets with CROMOGLYCATE DE SODIUM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| UNICROM 3M Collyre / 4% | 🇹🇳Tunisia | UNIMED | expired | Dec 2014 |
| UNICROM 3M Collyre / 2% | 🇹🇳Tunisia | UNIMED | expired | Dec 2014 |
| UNICROM Collyre / 2% | 🇹🇳Tunisia | UNIMED | expired | Mar 2011 |
| UNICROM Collyre / 4% | 🇹🇳Tunisia | UNIMED | expired | Aug 2004 |
| UNICROM OPHTADOSE Collyre monodose / 2% MG | 🇹🇳Tunisia | UNIMED | expired | Apr 2001 |
| UNICROM Collyre / 2% | 🇹🇳Tunisia | UNIMED | expired | Apr 1994 |
| CROMABAK COLLYRE | 🇲🇦Morocco | — | active | — |
| CUSICROM COLLYRE | 🇲🇦Morocco | — | active | — |
| OPTICRON COLLYRE | 🇲🇦Morocco | — | active | — |
| ALLERGO-COMOD COLLYRE | 🇲🇦Morocco | — | active | — |
| OPTICRON COLLYRE | 🇲🇦Morocco | — | active | — |
| OPTICRON collyre / 0,35 mg | 🇸🇳Senegal | COOPER FRANCE | active | — |
| CUSICROM COLLYRE | 🇲🇦Morocco | — | active | — |
| ALLERGOCROM COLLYRE | 🇲🇦Morocco | — | active | — |
| CROMEDIL 2 POUR CENT COLLYRE | 🇲🇦Morocco | — | active | — |
| CUSICROM COLLYRE | 🇲🇦Morocco | — | active | — |
| CROMOBAK collyre / 2% | 🇸🇳Senegal | THEA | active | — |
| CROMOLEX collyre / 2% | 🇸🇳Senegal | NIYA | active | — |
| CROMEDIL 2 POUR CENT COLLYRE | 🇲🇦Morocco | — | active | — |
| GROMEDIL collyre / 2% | 🇸🇳Senegal | EUROPHTA | active | — |
| CROMOLEX collyre / 2% | 🇸🇳Senegal | NIYA | active | — |
CROMOGLYCATE DE SODIUM in Africa — Regulatory Overview
CROMOGLYCATE DE SODIUM is registered across 3 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 15 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.